BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 34417303)

  • 1. SAMD9L autoinflammatory or ataxia pancytopenia disease mutations activate cell-autonomous translational repression.
    Russell AJ; Gray PE; Ziegler JB; Kim YJ; Smith S; Sewell WA; Goodnow CC
    Proc Natl Acad Sci U S A; 2021 Aug; 118(34):. PubMed ID: 34417303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ataxia-Pancytopenia Syndrome Is Caused by Missense Mutations in SAMD9L.
    Chen DH; Below JE; Shimamura A; Keel SB; Matsushita M; Wolff J; Sul Y; Bonkowski E; Castella M; Taniguchi T; Nickerson D; Papayannopoulou T; Bird TD; Raskind WH
    Am J Hum Genet; 2016 Jun; 98(6):1146-1158. PubMed ID: 27259050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germline SAMD9L truncation variants trigger global translational repression.
    Allenspach EJ; Soveg F; Finn LS; So L; Gorman JA; Rosen ABI; Skoda-Smith S; Wheeler MM; Barrow KA; Rich LM; Debley JS; Bamshad MJ; Nickerson DA; Savan R; Torgerson TR; Rawlings DJ
    J Exp Med; 2021 May; 218(5):. PubMed ID: 33724365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gain-of-function
    Tesi B; Davidsson J; Voss M; Rahikkala E; Holmes TD; Chiang SCC; Komulainen-Ebrahim J; Gorcenco S; Rundberg Nilsson A; Ripperger T; Kokkonen H; Bryder D; Fioretos T; Henter JI; Möttönen M; Niinimäki R; Nilsson L; Pronk CJ; Puschmann A; Qian H; Uusimaa J; Moilanen J; Tedgård U; Cammenga J; Bryceson YT
    Blood; 2017 Apr; 129(16):2266-2279. PubMed ID: 28202457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SAMD9 and SAMD9L in inherited predisposition to ataxia, pancytopenia, and myeloid malignancies.
    Davidsson J; Puschmann A; Tedgård U; Bryder D; Nilsson L; Cammenga J
    Leukemia; 2018 May; 32(5):1106-1115. PubMed ID: 29535429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Of gains and losses: SAMD9/SAMD9L and monosomy 7 in myelodysplastic syndrome.
    Cammenga J
    Exp Hematol; 2024 Jun; 134():104217. PubMed ID: 38649131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ataxia pancytopenia syndrome due to SAMD9L mutation presenting as demyelinating neuropathy.
    Vaughan D; Bogdanova-Mihaylova P; Costello DJ; Sweeney BJ; McNamara B; Walsh RA; Murphy SM
    J Peripher Nerv Syst; 2020 Dec; 25(4):433-437. PubMed ID: 32808377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of Hematopoietic Cell Transplantation in Patients with Germline SAMD9/SAMD9L Mutations.
    Ahmed IA; Farooqi MS; Vander Lugt MT; Boklan J; Rose M; Friehling ED; Triplett B; Lieuw K; Saldana BD; Smith CM; Schwartz JR; Goyal RK
    Biol Blood Marrow Transplant; 2019 Nov; 25(11):2186-2196. PubMed ID: 31306780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Association between SAMD9/SAMD9L and hematological malignancies].
    Narumi S; Hasegawa T
    Rinsho Ketsueki; 2018; 59(11):2475-2480. PubMed ID: 30531146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonal Elimination of the Pathogenic Allele as Diagnostic Pitfall in
    Eggermann K; Meyer R; Begemann M; Dey D; Bültmann E; Kurth I; Korenke GC; Knopp C
    Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel germline
    Cheah JJC; Brown AL; Schreiber AW; Feng J; Babic M; Moore S; Young CC; Fine M; Phillips K; Guandalini M; Wilson P; Poplawski N; Hahn CN; Scott HS
    Haematologica; 2019 Jul; 104(7):e318-e321. PubMed ID: 30923096
    [No Abstract]   [Full Text] [Related]  

  • 12. Pediatric MDS and bone marrow failure-associated germline mutations in SAMD9 and SAMD9L impair multiple pathways in primary hematopoietic cells.
    Thomas ME; Abdelhamed S; Hiltenbrand R; Schwartz JR; Sakurada SM; Walsh M; Song G; Ma J; Pruett-Miller SM; Klco JM
    Leukemia; 2021 Nov; 35(11):3232-3244. PubMed ID: 33731850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Constitutional
    Pastor VB; Sahoo SS; Boklan J; Schwabe GC; Saribeyoglu E; Strahm B; Lebrecht D; Voss M; Bryceson YT; Erlacher M; Ehninger G; Niewisch M; Schlegelberger B; Baumann I; Achermann JC; Shimamura A; Hochrein J; Tedgård U; Nilsson L; Hasle H; Boerries M; Busch H; Niemeyer CM; Wlodarski MW
    Haematologica; 2018 Mar; 103(3):427-437. PubMed ID: 29217778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukoencephalopathia, demyelinating peripheral neuropathy and dural ectasia explained by a not formerly described de novo mutation in the SAMD9L gene, ends 27 years of investigations - a case report.
    Thunström S; Axelsson M
    BMC Neurol; 2019 May; 19(1):89. PubMed ID: 31053103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing Long-Term Neurologic Outcomes in SAMD9L-Related Ataxia-Pancytopenia Syndrome.
    Zingariello CD; Chen DH; Raskind WH; Slayton WB; Subramony S; Severance J; Feagle M; Rasmussen SA
    Mov Disord Clin Pract; 2024 Jun; 11(6):728-733. PubMed ID: 38594844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New SAMD9L heterozygous mutation leading to myelodysplastic syndrome and acute myeloid leukemia: A case report and review of the literature.
    Monagel DA
    Cancer Rep (Hoboken); 2023 Apr; 6(4):e1797. PubMed ID: 36880537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of MIRAGE syndrome.
    Narumi S
    Pediatr Int; 2022 Jan; 64(1):e15283. PubMed ID: 35972063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case report:
    Caldirola MS; Seminario AG; Luna PC; Curciarello R; Docena GH; Fernandez Escobar N; Drelichman G; Gattorno M; de Jesus AA; Goldbach-Mansky R; Gaillard MI; Bezrodnik L
    Front Pediatr; 2023; 11():1108207. PubMed ID: 36969289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct interferon signatures and cytokine patterns define additional systemic autoinflammatory diseases.
    de Jesus AA; Hou Y; Brooks S; Malle L; Biancotto A; Huang Y; Calvo KR; Marrero B; Moir S; Oler AJ; Deng Z; Montealegre Sanchez GA; Ahmed A; Allenspach E; Arabshahi B; Behrens E; Benseler S; Bezrodnik L; Bout-Tabaku S; Brescia AC; Brown D; Burnham JM; Caldirola MS; Carrasco R; Chan AY; Cimaz R; Dancey P; Dare J; DeGuzman M; Dimitriades V; Ferguson I; Ferguson P; Finn L; Gattorno M; Grom AA; Hanson EP; Hashkes PJ; Hedrich CM; Herzog R; Horneff G; Jerath R; Kessler E; Kim H; Kingsbury DJ; Laxer RM; Lee PY; Lee-Kirsch MA; Lewandowski L; Li S; Lilleby V; Mammadova V; Moorthy LN; Nasrullayeva G; O'Neil KM; Onel K; Ozen S; Pan N; Pillet P; Piotto DG; Punaro MG; Reiff A; Reinhardt A; Rider LG; Rivas-Chacon R; Ronis T; Rösen-Wolff A; Roth J; Ruth NM; Rygg M; Schmeling H; Schulert G; Scott C; Seminario G; Shulman A; Sivaraman V; Son MB; Stepanovskiy Y; Stringer E; Taber S; Terreri MT; Tifft C; Torgerson T; Tosi L; Van Royen-Kerkhof A; Wampler Muskardin T; Canna SW; Goldbach-Mansky R
    J Clin Invest; 2020 Apr; 130(4):1669-1682. PubMed ID: 31874111
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.